Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:04 AM
Ignite Modification Date:
2025-12-25 @ 1:04 AM
NCT ID:
NCT07178093
Eligibility Criteria:
Inclusion Criteria:
* Sign the informed consent form
* Aged between 20 and 80
* Child-Pugh score class A, B
* Serum bilirubin level ≤ 1.5 times the upper limit of normal, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels ≤ 2 times the upper limit of normal
Exclusion Criteria:
* Unwillingness to sign the informed consent form
* Child-Pugh score class C
* Patients with main portal vein thrombosis
* Patients with diffuse liver tumors
* Those who are allergic to the contrast medium
* Those with abnormal coagulation function
* Those with severe dysfunction of brain, heart and lung
* Patients with severe renal dysfunction (except those receiving renal dialysis)
* Unable to cooperate
* Those with uncontrolled arrhythmia and unstable blood pressure
* Some patients with abnormal thyroid function
* Any other contraindications such as active gastrointestinal bleeding, refractory ascites, or severe portal hypertension
* Pregnant or lactating women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
80 Years
Study:
NCT07178093
Study Brief:
Protocol Section:
NCT07178093